4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:临床生物学、分子生物学、实验室设备、耗材、免疫学及免疫血液等
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > cytokine > Biovendor/ANG-1 Human HeLa cells/RBG10057020/20 µg
商品详细Biovendor/ANG-1 Human HeLa cells/RBG10057020/20 µg
Biovendor/ANG-1 Human HeLa cells/RBG10057020/20 µg
Biovendor/ANG-1 Human HeLa cells/RBG10057020/20 µg
商品编号: RBG10057020
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 细胞因子
公司分类: cytokine
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
  • Regulatorystatus:RUO
  • Type:Recombinant
  • Source:HeLacells
  • Othernames:Angiopoietin-1,ANGPT1,KIAA0003
  • Species:Human

Type

Recombinant

Description

Angiopoietin-1(Ang-1)isasecretedligandforTie-2,atyrosine-kinasereceptorexpressedprimarilyonvascularendothelialcellsandearlyhematopoieticcells.Ang-1/Tie-2 signalingpromotesangiogenesisduringthedevelopment,remodeling,andrepairofthevascularsystem.TransgenicmicelackingexpressionofeitherAng-1 orTie-2 failtodevelopafullyfunctionalcardiovascularsystemanddiebeforebirth.Postnatally,theangiogenicactivityofAng-1/Tie-2 isrequiredduringnormaltissuerepairandremodelingofthefemaleendometriuminthemenstrualcycle.Ang-1/Tie-2 signalingappearstoberegulatedbyAngiopoietin-2(Ang-2),anaturalantagoNISTforTie-2 thatexertsitseffectsthroughaninternalautocrineloopmechanism.Inadditiontosuppressingendothelialcellactivationbyinhibitingtheexpressionofadhesionandinflammatorymolecules,Ang-1 enhancesendothelialcellsurvivalandcapillarymorphogenesis,andlessenscapillarypermeABIlity.Assuch,Ang-1 haspotentialtobecomeaneffectivetherapeuticagentfortreatingvariousendotheliumdisorders,includingseveralseverehumanpulmonarydiseases.Theefficacyofcell-basedAng-1 genetherapyforacutelunginjury(ALI)hasrecentlybeenstudiedinaratmodelofALI.TheresultsofthisstudyshowthatsuchtherapycanmarkedlyimprovelungconditionandsuggestthatAng-1 therapymayrepresentapotentialnewstrategyforthetreatmentand/orpreventionofacuterespiratorydistressinjury(ARDI),asignificantcauseofmorbidityandmortalityincriticallyillpatients.RecombinanthumanANG-1,derivedfromHeLacells,isaC-terminalhistidinetaggedglycoproteinwhichmigrateswithanapparentmolecularmassof60.0 –70.0 kDabySDS-PAGEunderreducingconditions.SequencinganalysisshowsN-terminalsequencesstartingwithSer-20 andwithAsp-70 ofthe498 aminoacidprecursorprotein.ThecalculatedmolecularweightofRecombinantHumanANG-1 is56.3 kDa.

AminoAcidSequence

SNQRRSPENSGRRYNRIQHGQCAYTFILPEHDGNCRESTTDQYNTNALQRDAPHVEPDFSSQKLQHLEHVMENYTQWLQKLENYIVENMKSEMAQIQQNAVQNHTATMLEIGTSLLSQTAEQTRKLTDVETQVLNQTSRLEIQLLENSLSTYKLEKQLLQQTNEILKIHEKNSLLEHKILEMEGKHKEELDTLKEEKENLQGLVTRQTYIIQELEKQLNRATTNNSVLQKQQLELMDTVHNLVNLCTKEGVLLKGGKREEEKPFRDCADVYQAGFNKSGIYTIYINNMPEPKKVFCNMDVNGGGWTVIQHREDGSLDFQRGWKEYKMGFGNPSGEYWLGNEFIFAITSQRQYMLRIELMDWEGNRAYSQYDRFHIGNEKQNYRLYLKGHTGTAGKQSSLILHGADFSTKDADNDNCMCKCALMLTGGWWFDACGPSNLNGMFYTAGQNHGKLNGIKWHYFKGPSYSLRSTTMMIRPLDFHHHHHH

Source

HeLacells

Purity

95%

BIOLOGicalActivity

Determinedbythedose-dependentstimulationoftheproliferationofhumanumbilicalveinendothelialcells(HUVEC).

Storage/Expiration

 –20°C

品牌介绍
miREIA是一种基于免疫测定的新型miRNA定量方法,涉及从患者样品中分离出的miRNA与互补的生物素化DNA寡核苷酸探针杂交。然后通过固定有完美匹配的DNA / miRNA杂交体的微量滴定板固定的单克隆抗体捕获DNA / RNA杂交体。下一步是复制标准ELISA方案。该测定可在常规免疫测定设备上运行,与标准临床工作流程兼容,不需要扩增步骤,并且包括miRNA分析在内的结果可在不到三个小时的时间内获得。